Form 8-K · Current report
Lennox International 8-K, filed Jul 29, 2026
- Filed
- CIK
- 0001069202
- Accession no.
- 0001069202-26-000085
Summary
Lennox International reported second-quarter 2026 revenue of $1.5 billion, up 3%, GAAP operating income of $355 million, up 2%, and GAAP diluted earnings per share flat at $7.72, and lowered its full-year 2026 EPS guidance to $23.00–$24.00 from a prior range of $23.50–$25.00 while reaffirming revenue growth of about 8%.
Key points
- Building Climate Solutions revenue rose 24% (15% organic) while Home Comfort Solutions revenue fell 7% on lower residential volumes.
- Lennox reaffirmed full-year 2026 revenue growth guidance of approximately 8%, including a 5% benefit from completed acquisitions, and kept free cash flow guidance at $750 million to $850 million.
- CEO Alok Maskara said strength in Building Climate Solutions and contributions from the Duro Dyne and Supco acquisitions mitigated continued softness in the residential end market.
- Net income was $269 million versus $274 million a year earlier, and share repurchases totaled $132 million.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition.* On July 29, 2026, Lennox International Inc. (the “Company”) issued a press release announcing its financial results for the second quarter of 2026. A copy of the press release is furnished as Exhibit 99.1 to this report. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. EXHIBIT NUMBER DESCRIPTION 99.1 Press release dated July 29, 2026 (furnished herewith).* 104 Inline XBRL for the cover page of this Current Report on Form 8-K. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.